Background: Light interventions typically exert their mood-related effects during morning bright light exposures over several weeks. Evidence about immediate ambient room light effects on depressed individuals is still sparse. Objective: The present study aimed at examining the acute effects of a single moderately bright room light exposure on mood, and behavioural and cardiac stress reactions of mildly depressed geriatric inpatients during a short cognitive stimulation and while resting. Methods: Twenty-one inpatients were tested in a balanced cross-over design on 2 consecutive days under either conventional room light (standard light) or artificial sunlight conditions for 30 min. Room illumination was implemented with an artificial skylight, which perfectly imitated solar indoor illumination (e.g., cloudless sky and bright artificial sun). Light-induced changes of mood, heart rate, and heart rate variability were recorded while performing a perseveration test (acted as cognitive stimulation) twice. Additionally, light-related behaviour was observed during a resting period between the cognitive tests and various subjective ratings were obtained. Results: Compared to standard light, exposure to artificial sunlight had a subjective calming effect over time (p = 0.029) as well as decreased heart rate and increased vagal tone (root mean squared of successive inter-beat intervals), both under cognitive workload and in resting conditions. Effect sizes of reported cardiac reactions were large. Cognitive variables were not influenced by light. Additionally, under the higher corneal illuminance of the artificial sunlight, patients perceived stronger glare (p = 0.030) and kept their eyes closed for longer times (p = 0.033) during the resting period. However, patients did not avoid bright light exposure while resting but voluntarily stayed within the area directly lit by the artificial sun nearly all the time (97%). Conclusion: To our knowledge, this study for the first time demonstrated immediate psychophysiological effects of a single, short room light exposure in mildly depressed geriatric inpatients during a short cognitive stimulation and while resting. The findings complement reported evidence on immediate alerting and mood-related effects of bright light exposures.

Keywords:
Bright light, Geriatric, Depression, Mood, Heart rate, Heart rate variability, Artificial sunlight
1.
Shirani A, St Louis EK: Illuminating rationale and uses for light therapy. J Clin Sleep Med 2009;5:155-163.
2.
Bassa D, Canazei M, Hinterhuber H, Weiss E: The current state of research in bright light therapy. Neuropsychiatry 2013;27:142-148.
3.
Weiss E, Canazei M: The influence of light on mood and emotion; in Mohiyeddin C, Eysenck M, Bauer S (eds): Handbook of Psychology of Emotions. New York, Nova Science Publishers, chapter 17, pp 297-306.
4.
Hickman SE, Barrick AL, Williams CS, Zimmermann S, Connell BR, Preisser JS, Mitchell CM, Sloane PD: The effect of ambient bright light therapy on depressive symptoms in persons with dementia. J Am Geriatr Soc 2007;55:1817-1824.
5.
Riemersma-van der Lek RF, Swaab DF, Twisk J, Hol EM, Hoogendijk WJ, Van Someren EJ: Effect of bright light and melatonin on cognitive and non-cognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 2008;299:2642-2655.
6.
Figueiro MG, Hunter CM, Higgins P, Hornick T, Jones GE, Plitnick B, Brons J, Rea MS: Tailored lighting intervention for persons with dementia and caregivers living at home. Sleep Health 2015;1:322-330.
7.
Thalen BE, Kjellman BF, Morkrid L, Wibom R, Wetterberg L: Light treatment in seasonal and nonseasonal depression. Acta Psychiatr Scand. 1995;91:352-360.
8.
Rastad C, Ulfberg J, Lindberg P: Light room therapy effective in mild forms of seasonal affective disorder - a randomized controlled study. J Affect Disord 2008;108:291-296.
9.
Young SN: How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci 2007;32:394-399.
10.
Cawley EI, Park S, aan het Rot M, Sancton K, Benkelfat C, Young SN, Boivin DB, Leyton M: Dopamine and light dissecting effects on mood and motivational states in women with subsyndromal seasonal affective disorder. J Psychiatry Neurosci 2013;38:388-397.
11.
Winkler D, Pjrek E, Praschak-Rieder N, Willeit M, Pezawas L, Konstantinidis A, Statstny J, Kasper S: Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapy. Biol Psychiatry 2005;58:331-336.
12.
Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD: Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoceptor. J Neurosci 2001;21:6405-6412.
13.
Lucas RJ, Peirson SN, Berson DM, Browen TM, Cooper HM, Czeisler CA, Figueiro MG, Gamlin PD, Lockley SW, O'Hagan JB, Price LL, Provencio I, Skene DJ, Brainard GC: Measuring and using light in the melanopsin age. Trends Neurosci 2014;37:1-9.
14.
Vandewalle G, Balteau E, Phlips C, Degueldre C, Moreau V, Sterpenich V, Albouy G, Darsaud A, Desseilles M, Dang-Vu TT, Peigneux P, Luxen A, Dijk DJ, Maquet P: Daytime light exposure dynamically enhances brain responses. Curr Biol 2006;16:1616-1621.
15.
Vandewalle G, Schwartz S, Grandjean D, Wuillaume C, Balteau E, Degueldre C, Schabus M, Philips C, Luxen A, Dijk DJ, Maquet P: Spectral quality of light modulates emotional responses in humans. Proc Natl Acad Sci USA 2010;107:19549-19554.
16.
Scheer FA, Kalsbeek A, Buijs RM: Cardiovascular control by the suprachiasmatic nucleus: neural and neuroendocrine mechanisms in human and rat. Biol Chem 2003;384:697-709.
17.
Scheer FA, Van Doornen LJ, Buijs RM: Light and diurnal cycle affect autonomic cardiac balance in human-possible role for the biological clock. Auton Neurosci 2004;110:44-48.
18.
Rechlin T, Weis M, Schnieder K, Zimmermann U, Kaschka WP: Does bright-light therapy influence autonomic heart-rate parameters? J Affect Disord 1995;34:131-137.
19.
Choi CJ, Kim KS, Kim CM, Kim SH, Choi WS: Reactivity of heart rate variability after exposure to coloured lights in healthy adults with symptoms of anxiety and depression. Int J Psychophysiol 2011;79:83-88.
20.
Folstein MF, Folstein SE, McHugh PR: Mini-mental state. A practical method for grading the state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
21.
Faul F, Erdfelder E, Buchner A, Lang AG: Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009;41:1149-1160.
22.
Wendt G, Binz U, Müller AA: KUSTA (Kurz-Skala Stimmung/Aktivierung): a daily self-rating scale for depressive patients. Pharmacopsychiatry 1985;18:118-122.
23.
Schulter G, Mittenecker E, Papousek I: A computer program for testing and analysing random generation behaviour in normal and clinical samples: the Mittenecker Pointing Test. Behav Res Methods 2010;42:333-341.
24.
Lantelme P, Milon H, Gharib C, Gayet C, Fortrat JO: White coat effect and reactivity to stress: cardiovascular and autonomic nervous system responses. Hypertension 1998;31:1021-1029.
25.
Shcheslavskaya OV, Burg MM, McKinley PS, Schwartz JE, Gerin W, Ryff CD, Weinstein M, Seeman TE, Sloan RP: Heart rate recovery after cognitive challenge is preserved with age. Psychosom Med 2010;72:128-133.
26.
Yesavage JA, Sheikh JI: Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986;5:165-173.
27.
Ulrich RS: Aesthetic and affective response to natural environment; in Altman I, Wohlwill F (eds): Behaviour and the Natural Environment. New York, Springer, 1983, pp 85-125.
28.
Berto, R: The role of nature in coping with psycho-physiological stress: a literature review on restorativeness. Behav Sci 2014;4:394-409.
29.
Canazei M, Laner M, Staggl S, Pohl W, Ragazzi P, Magatti D, Martinelli E, Di Trapani P: Room- and illumination-related effects of an artificial skylight. Light Res Technol 2016;48:539-558.
30.
Owsley C: Aging and vision. Vision Res 2011;51:1610-1622.
31.
Gerbaldo H: Depression and photophobic behavior. Am J Psychiatry 1988;145:1479-1480.
32.
Virk G, Reeves G, Rosenthal NE, Sher L, Postolache TT: Short exposure to light treatment improves depression scores in patients with seasonal affective disorder: a brief report. Int J Disabil Hum Dev 2009;8:283-286.
33.
Kopp BT, Hayes D, Ratkiewicz M, Baron N, Splaingard M: Light exposure and depression in hospitalized adult patients with cystic fibrosis. J Affect Dis 2013;150:585-589.
34.
Chang AM, Scheer FAJL, Czeisler CA: The human circadian system adapts to prior photic history. J Physiol 2011;589:1095-1102.
35.
Agelink MW, Boz C, Ullrich H, Andrich J: Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Res 2002;113:139-149.
36.
Licht CM, de Geus EJ, Zitman FG, Hoogendijk WJ, van Dyck R, Penninx BW: Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry 2008;65:1358-1367.
37.
Alvares GA, Quintana DS, Hickie IB, Guastella AJ: Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis. J Psychiatry Neurosci 2016;41:89-104.
38.
Carthy E: Autonomic dysfunction in essential hypertension: a systematic review. Ann Med Surg 2014;3:2-7.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.